AU2003242988A1 - Process for the preparation of the anti-cancer drug imatinib and its analogues - Google Patents
Process for the preparation of the anti-cancer drug imatinib and its analoguesInfo
- Publication number
- AU2003242988A1 AU2003242988A1 AU2003242988A AU2003242988A AU2003242988A1 AU 2003242988 A1 AU2003242988 A1 AU 2003242988A1 AU 2003242988 A AU2003242988 A AU 2003242988A AU 2003242988 A AU2003242988 A AU 2003242988A AU 2003242988 A1 AU2003242988 A1 AU 2003242988A1
- Authority
- AU
- Australia
- Prior art keywords
- analogues
- preparation
- cancer drug
- drug imatinib
- imatinib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2003/000211 WO2004108699A1 (en) | 2003-06-06 | 2003-06-06 | Process for the preparation of the anti-cancer drug imatinib and its analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003242988A1 true AU2003242988A1 (en) | 2005-01-04 |
Family
ID=33495846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003242988A Abandoned AU2003242988A1 (en) | 2003-06-06 | 2003-06-06 | Process for the preparation of the anti-cancer drug imatinib and its analogues |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003242988A1 (en) |
WO (1) | WO2004108699A1 (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA013328B1 (en) | 2004-09-09 | 2010-04-30 | Натко Фарма Лимитед | Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase |
SI1833815T1 (en) * | 2004-12-30 | 2011-01-31 | Inst Farmaceutyczny | A process for preparation of imatinib base |
US7977348B2 (en) | 2006-04-27 | 2011-07-12 | Sicor Inc. | Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α |
US8067421B2 (en) | 2006-04-27 | 2011-11-29 | Sicor Inc. | Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α |
EP1988089A1 (en) | 2006-10-26 | 2008-11-05 | Sicor, Inc. | Imatinib base, and imatinib mesylate and processes for preparation thereof |
WO2008070350A2 (en) | 2006-10-27 | 2008-06-12 | The Board Of Regents Of The University Of Texas System | Methods and compositions related to wrapping of dehydrons |
US8168787B2 (en) | 2006-11-16 | 2012-05-01 | F.I.S. Fabbrica Italiana Sintetici S.P.A. | Process for the preparation of imatinib and intermediates thereof |
CN100451015C (en) * | 2007-02-14 | 2009-01-14 | 杭州盛美医药科技开发有限公司 | Preparing method of imatinib |
WO2008117298A1 (en) * | 2007-03-26 | 2008-10-02 | Natco Pharma Limited | A novel method of preparation of imatinib |
JP2010540465A (en) | 2007-09-25 | 2010-12-24 | テバ ファーマシューティカル インダストリーズ リミティド | Stable imatinib composition |
EP2231161A1 (en) * | 2007-12-22 | 2010-09-29 | Synthon B.V. | A process of making imatinib |
PL215042B1 (en) * | 2008-08-01 | 2013-10-31 | Temapharm Spolka Z Ograniczona Odpowiedzialnoscia | Method of imatinib manufacturing |
US20100330130A1 (en) | 2009-05-22 | 2010-12-30 | Actavis Group Ptc Ehf | Substantially pure imatinib or a pharmaceutically acceptable salt thereof |
CN102070604B (en) * | 2009-11-20 | 2014-06-25 | 成都弘达药业有限公司 | Method for preparing imatinib free alkali |
WO2011095835A1 (en) | 2010-02-02 | 2011-08-11 | Actavis Group Ptc Ehf | Highly pure imatinib or a pharmaceutically acceptable salt thereof |
KR20130055576A (en) * | 2010-03-15 | 2013-05-28 | 낫코 파마 리미티드 | Process for the preparation of highly pure crystalline imatinib base |
WO2011130918A1 (en) | 2010-04-23 | 2011-10-27 | 上海百灵医药科技有限公司 | Process for synthesizing imatinib |
SI2582689T1 (en) | 2010-06-18 | 2017-05-31 | Krka, D.D., Novo Mesto | New polymorphic form of imatinib base and preparation of salts thereof |
CN102372690B (en) * | 2010-08-20 | 2014-05-28 | 成都地奥制药集团有限公司 | Intermediate for synthesizing imatinib and application of intermediate in imatinib synthesis |
TR201007005A2 (en) | 2010-08-23 | 2011-09-21 | Mustafa Nevzat İlaç Sanayi̇i̇ A.Ş. | Imatinib base production method |
KR101367228B1 (en) * | 2010-10-22 | 2014-03-14 | 상하이 팔링 파마테크 씨오., 엘티디. | New method for Synthesiging Imatinib |
CN102382100B (en) * | 2011-03-09 | 2014-04-16 | 上海昕盛医药科技有限公司 | Preparation method of imatinib |
CN102731474B (en) * | 2011-04-13 | 2014-12-03 | 石药集团中奇制药技术(石家庄)有限公司 | Preparation method of imatinib |
CN102796110B (en) * | 2011-05-23 | 2016-03-30 | 复旦大学 | Aniline pyrimidine compound and its production and use |
CN102863383A (en) * | 2011-07-08 | 2013-01-09 | 华东理工大学 | Preparation method of oxygen bleaching activator tribasic copper chloride (TBCC) |
WO2013035102A1 (en) | 2011-09-05 | 2013-03-14 | Natco Pharma Limited | Processes for the preparation of imatinib base and intermediates thereof |
US20140343282A1 (en) | 2013-05-16 | 2014-11-20 | Apicore, Llc | Processes for making ponatinib and intermediates thereof |
CN104230884B (en) * | 2013-06-09 | 2016-06-08 | 北大方正集团有限公司 | Imatinib intermediate and its preparation method |
CN103420976B (en) * | 2013-07-26 | 2014-12-10 | 天津禾盛医药技术开发有限公司 | Method for preparing imatinib and mesylate |
US9988389B2 (en) * | 2015-06-11 | 2018-06-05 | Apicore Us Llc | Processes for making ponatinib and intermediates thereof |
EP3333162A1 (en) | 2016-12-12 | 2018-06-13 | Silesian Catalysts sp. z o.o. | Metod for preparing n-(2-methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine |
DE102017004596B4 (en) | 2017-05-13 | 2021-02-11 | Alzchem Trostberg Gmbh | Process for the production of phenylguanidines or their salts |
CN108358776A (en) * | 2018-01-29 | 2018-08-03 | 江苏佳麦化工有限公司 | The preparation method of 4- chloromethyl benzoic acid chlorides |
CN111909024B (en) * | 2019-05-08 | 2022-08-02 | 金凯(辽宁)生命科技股份有限公司 | Preparation method of 4-formylbenzoic acid |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
GB0022438D0 (en) * | 2000-09-13 | 2000-11-01 | Novartis Ag | Organic Compounds |
EP1395261B1 (en) * | 2001-05-16 | 2006-06-28 | GPC Biotech AG | Pyridylpyrimidine derivatives as effective compounds against prion diseases |
GB0202873D0 (en) * | 2002-02-07 | 2002-03-27 | Novartis Ag | Organic compounds |
-
2003
- 2003-06-06 WO PCT/IN2003/000211 patent/WO2004108699A1/en active Application Filing
- 2003-06-06 AU AU2003242988A patent/AU2003242988A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004108699A1 (en) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003242988A1 (en) | Process for the preparation of the anti-cancer drug imatinib and its analogues | |
IL183583A (en) | Quinazoline derivatives and pharmaceutical compositions containing the same and processes for producing the same | |
IL189657A (en) | Process for the preparation of n-phenyl-2-pyrimidine-amine derivatives | |
IL163831A0 (en) | Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing | |
WO2006015081A3 (en) | A PROCESS FOR THE PREPARATION OF 7α-ALKYLATED 19-NORSTEROIDS | |
EP1731139A4 (en) | S/o type pharmaceutical preparation and process for producing the same | |
PL1731138T3 (en) | Fine dispersion of sparingly soluble drug and process for producing the same | |
IL166621A0 (en) | Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same | |
IL181022A0 (en) | Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same | |
AU2002341241A1 (en) | Process for the preparation of fast dissolving dosage form | |
IL175743A0 (en) | Process for the preparation of thiazolopyrimidines | |
IL171789A (en) | Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin | |
AU2003260983A1 (en) | Processes for the preparation of s-(-)-amlodipine | |
AU2003286944A1 (en) | Crude drug compositions and the process for preparing them | |
AU2003282375A1 (en) | Pharmaceutical compositions and process of production thereof | |
AU2003245880A1 (en) | Process for the preparation of thioalkylamine derivatives | |
AU2002367890A1 (en) | Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate | |
EP1646640A4 (en) | Method for the preparation of highly pure 1-androstene derivatives | |
AU2003270202A1 (en) | Pharmaceutical compositions increasing camp useful for the treatment of cancers | |
AU2003300018A1 (en) | Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents | |
HK1095145A1 (en) | Process for the preparation of n-arylmorpholinones n- | |
AU2002359034A1 (en) | Process for the preparation of simvastatin | |
GB0327742D0 (en) | Novel uses of known drugs | |
AUPR520701A0 (en) | Herbal composition for the treatment of drug addiction | |
HK1087111A1 (en) | Process for the preparation of nicotinaldehydes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |